Format

Send to

Choose Destination
J Vis Exp. 2018 May 31;(135). doi: 10.3791/57188.

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes.

Author information

1
Department of Pathology, Sackler School of Medicine, Tel-Aviv University.
2
Department of Pathology, School of Medicine, Stanford University.
3
Department of Pathology, Sackler School of Medicine, Tel-Aviv University; yaron.carmi@gmail.com.

Abstract

Dendritic cells (DC) are heterogeneous cell populations that differ in their cell membrane markers, migration patterns and distribution, and in their antigen presentation and T cell activation capacities. Since most vaccinations of experimental tumor models require millions of DC, they are widely isolated from the bone marrow or spleen. However, these DC significantly differ from blood and tumor DC in their responses to immune complexes (IC), and presumably to other Syk-coupled lectin receptors. Importantly, given the sensitivity of DC to danger-associated molecules, the presence of endotoxins or antibodies that crosslink activation receptors in one of the isolating steps could result in the priming of DC and thus affect the parameters, or at least the dosage, required to activate them. Therefore, here we describe a detailed protocol for isolating MoDC from blood and tumors while avoiding their premature activation. In addition, a protocol is provided for MoDC activation with tumor IC, and their subsequent analyses.

PMID:
29912184
PMCID:
PMC6101436
[Available on 2020-05-31]
DOI:
10.3791/57188
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for MyJove Corporation
Loading ...
Support Center